CHAP Annual Network Meetings

CHAP meets once a year, in conjunction with the annual Canadian Conference on HIV/AIDS Research (CAHR).
All members are welcome to attend this meeting.

2021 Meeting

• 2021 Meeting Agenda
• 2021 Meeting Minutes

2020 Meeting

• 2020 Meeting Agenda
• 2020 Meeting Minutes

2019 Meeting

• 2019 Meeting Agenda
• 2019 Presentation Files

2018 Meeting

• 2018 Meeting Agenda
• 2018 Meeting Minutes

2017 Meeting

• 2017 Meeting Agenda
• 2017 Meeting Minutes

2016 Meeting

• 2016 Meeting Agenda
• 2016 Meeting Minutes

2015 Meeting

• 2015 Meeting Agenda
• 2015 Meeting Minutes

2014 Meeting

• 2014 Meeting Agenda
• 2014 Meeting Minutes

2013 Meeting

• 2013 Meeting Agenda
• 2013 Meeting Minutes

2012 Meeting

• 2012 Meeting Agenda
• 2012 Meeting Minutes

2011 Meeting

• 2011 Meeting Agenda
• 2011 Meeting Minutes
• Drug Interaction Cases (R. Therrien)

2010 Meeting

• 2010 Meeting Agenda
• 2010 Meeting Minutes
• 2010 HIV Pharmacology Workshop Update (Pierre, Alice)

2009 Meeting

• 2009 Meeting Agenda
• 2009 Meeting Minutes
• Update on the 10th International Workshop of Clinical Pharmacology of HIV Therapy (Pierre Giguere)

2008 Meeting

• 2008 Meeting Agenda
• 2008 Meeting Minutes

2007 Meeting

• 2007 Meeting Agenda
• 2007 Meeting Minutes

2006 Meeting

• 2006 Meeting Agenda
• 2006 Meeting Minutes
• Metabolic Complications of HIV Therapy (Dr. Roger LeBlanc, MD. FRCPC)
• CROI 2006 Conference Update (Alice Tseng, Pharm. D.)
• HIV Pharmacology Workshop 2006 Update (Nancy Sheehan, M.Sc.Phm.)

2005 Meeting

• 2005 Meeting Agenda
• 2005 Meeting Minutes
• Update from the HIV Resistance Workshop, Athens 2005 (Christine)
• HIV Pharmacology Update (Alice, Elizabeth)
• Atazanavir Update (BMS)
• Antiretroviral PK/PD Modeling (Line Labbe)
• Nelfinavir PK in the Aged Study (Nancy)

2004 Meeting

• 2004 Meeting Agenda
• 2004 Meeting Minutes
• 5th International Workshop on Clinical Pharmacology of HIV Therapy(Posters)
• 5th International Workshop on Clinical Pharmacology of HIV Therapy (Oral)
• Atazanavir: Clinical & Metabolic Overview
• The Effect of Atazanavir vs. Lopinavir/Ritoavir on Insulin-Stimulated Glucose Disposal Rate in Healthy Subjects (Poster)
• TDM Case

2003 to 1999 Meetings

• 2003 Meeting Agenda
• 2002 Meeting Agenda
• 2002 Meeting Minutes
• 2001 Meeting Agenda
• 2001 Meeting Minutes
• 2000 Meeting Agenda
• 2000 Meeting Minutes
• 1999 Meeting Agenda
• 1999 Meeting Minutes